STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 89 filers reported holding STOKE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,639,500 | +45.8% | 394,312 | +102.8% | 0.00% | 0.0% |
| Q3 2022 | $2,496,250 | -2.8% | 194,412 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,568,183 | -16.2% | 194,412 | +33.5% | 0.00% | 0.0% |
| Q1 2022 | $3,064,880 | +166.5% | 145,600 | +222.1% | 0.00% | – |
| Q3 2021 | $1,150,000 | +114.2% | 45,200 | +80.8% | 0.00% | – |
| Q3 2019 | $537,000 | -26.3% | 25,000 | 0.0% | 0.00% | – |
| Q2 2019 | $729,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |